Hidden danger: toxoplasmosis in Non-HIV patients under the microscope
NCT ID NCT07299500
First seen Jan 05, 2026 · Last updated Jun 07, 2026 · Updated 20 times
Summary
This study looks back at the medical records of 30 immunocompromised patients (like organ transplant recipients or those on immune-suppressing drugs) who had toxoplasmosis. The goal is to understand how many are affected and how to better diagnose, treat, and prevent this infection. No new treatments are being tested—just gathering information to improve future care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CEREBRAL TOXOPLASMOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Service d'immunologie clinique - Hôpitaux Universitaires de Strasbourg
RECRUITINGStrasbourg, 67091, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.